基于CiteSpace和VOSviewer对女贞子的研究现状与热点分析  

Research Status and Hotspot Analysis of Ligustrumlucidum based on CiteSpace and VOSviewer

作　　者：韩昕 李莎莎 陈曦[1] 毛阿娟 李凡[2] 王卫锋[2] 李芳[2] HAN Xin;LI Shasha;CHEN Xi;MAO Ajuan;LI Fan;WANG Weifeng;LI Fang(Shaaxi University of Chinese Medicine,Xiangyang 712046,China;Shaanxi Provincial Academy of Traditional Chinese Medicine,Xi'an 710003,China)

机构地区：[1]陕西中医药大学,陕西咸阳712046 [2]陕西省中医药研究院,陕西西安710003

出　　处：《特产研究》2024年第3期47-55,59,共10页Special Wild Economic Animal and Plant Research

基　　金：国家陕西省中医药管理局项目(2021-QYZL-01)。

摘　　要：利用CiteSpace和VOSviewer对女贞子近三十年的中文文献进行计量学分析,以探究女贞子的研究现状及发展趋势。本研究整理收集中国知网、维普、万方及中国生物医学文献数据库中近三十年(1993年至2023年)女贞子相关研究文献,通过Java语言环境下的VOSviewer与CiteSpace软件对其发文量、作者、发文机构、关键词进行可视化分析。本文纳入的1 240篇文献可视化,结果显示,发文量最多的作者是刘慧仁(首都医科大学);发文量最多的机构是山东中医药大学(22篇);通过对关键词的分析发现,女贞子的研究热点集中在化学成分的测定、质量标准的制定、药理作用的探索、配伍机制的研究、“女贞子-墨旱莲”(二至丸)的配伍、临床经验的总结等方面。当前,女贞子研究的重点和热点是复方(中药)/治疗应用、化学成分分析和“二至丸”配伍分析。To analyze the Chinese literature on Ligustrumlucidum in the last thirty years by using CiteSpace and VOSviewer for econometric analysis,in order to explore the current research status and development trend of Ligustri lucidi.We organized and collected the research literature related to Nvzhenzi in the last thirty years(1993 to 2023)fromChina Knowledge Resources Network,VIP Database,Wanfang Database,and China Biomedical Literature Database,and visualized and analyzed the number of articles,authors,institutions,and keywords by using VOSviewer and CiteSpace software in Java language environment.The visualization results of the included 1240 documents in this study.The results showed that:the author with the most publications was Liu Huiren(Capital Medical University);the institution with the most publications was Shandong university of traditional chinese medicine(22).An analysis of the keywords reveals that the main research hotspots of Nvzhenzi are focused on the determination of chemical constituents,the development of quality standards,the exploration of pharmacological effects,the study of the mechanism of compounding,the compounding of Ligustrum lucidum-Edipta prostrate(Er Zhi Pill),and the summary of clinical experience.At present,compound(TCM)/therapeutic applications,chemical composition analysis,and analysis of the"Er Zhi Pill"formula are the focus and hotspots of Ligustri lucidi fructus.

关 键 词：女贞子 CITESPACE VOSviewer 可视化分析 文献计量学 

分 类 号：R284[医药卫生—中药学] G353.1[医药卫生—中医学]